Oxybutynin 5 mg Immediate Release Tablets — Generic For Ditropan — Leading Pharma

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Oxybutynin chloride tablets are an oral antispasmodic and anticholinergic medicine. Each scored, round, uncoated tablet contains 5 mg of oxybutynin chloride.

This medicine is indicated for relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder. Symptoms listed on the label include urgency, frequency, urinary leakage, urge incontinence, and dysuria.

The label says oxybutynin relaxes bladder smooth muscle and can increase bladder capacity, decrease involuntary bladder contractions, and reduce urgency and frequency of urination. It should be used with caution in certain patients because it may cause anticholinergic side effects and other risks listed on the label.

Storage Information

Store at 20° to 25°C (68° to 77°F); excursions permitted within 15°C to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in tight, light-resistant container as defined in the USP.

Key Counseling Points

• Take oxybutynin by mouth exactly as directed on the prescription label.
• The usual adult dose on the label is one 5 mg tablet 2 to 3 times a day; do not exceed the maximum recommended dose on the label.
• For pediatric patients over 5 years of age, the label lists a usual dose of one 5 mg tablet 2 times a day and a maximum of one 5 mg tablet 3 times a day.
• The label warns that oxybutynin can cause dry mouth, constipation, dizziness, somnolence, blurred vision, and urinary retention.
• The label says angioedema can occur, including swelling of the face, lips, tongue, or larynx; seek immediate medical attention for tongue swelling or difficulty breathing.
• Be cautious with activities requiring alertness if you notice drowsiness or blurred vision.
• Alcohol may enhance the drowsiness caused by oxybutynin, according to the label.
• Report signs of heat prostration, such as fever or heat stroke due to decreased sweating, as described on the label.
• Tell a clinician about other anticholinergic medicines or drugs that may affect drowsiness, dry mouth, constipation, or gastrointestinal motility.
• The label states this medicine should be used with caution in people with urinary retention, gastric retention, severe decreased gastrointestinal motility, uncontrolled narrow-angle glaucoma, and certain other conditions.

Helpful Patient Education

Oxybutynin chloride tablets USP 5 mg are oral antispasmodic and anticholinergic tablets used for relief of bladder instability symptoms associated with uninhibited neurogenic or reflex neurogenic bladder. The label describes benefits such as reduced urgency, frequency, urinary leakage, urge incontinence, and dysuria.

This DailyMed label also lists important safety information, including contraindications, possible anticholinergic central nervous system effects, interactions with other anticholinergic drugs, and commonly reported adverse reactions such as dry mouth, constipation, dizziness, somnolence, blurred vision, and urinary retention.

Medication Summary last generated: 2026-07-06 03:13:51